Group 1 - The core point of the news is that Guangxi Liuyuan Group Co., Ltd. won a procurement project from the Guangxi Zhuang Autonomous Region Maternal and Child Health Hospital, with a bid amount of 4.76 million yuan [1][2] Group 2 - In 2024, the company's operating revenue was 21.182 billion yuan, with a growth rate of 1.78% [2] - The net profit attributable to the parent company for 2024 was 855 million yuan, with a growth rate of 0.62% [2] - The return on equity was 11.62% [2] - In the first half of 2025, the company's operating revenue was 10.301 billion yuan, with a decline of 3.21% [2] - The net profit attributable to the parent company for the first half of 2025 was 429 million yuan, with a decline of 7.52% [2] Group 3 - The company operates in the daily consumer industry, with main product types including biological diagnostic reagents, organic chemical pesticides, diagnostic treatment equipment, and traditional Chinese medicine pieces [2] - The main business composition in 2024 was: pharmaceuticals 85.41%, medical devices 13.45%, others 0.74%, and other businesses 0.4% [2]
柳药集团(603368):中标广西壮族自治区妇幼保健院采购项目,中标金额为476.00万元